Our Biologics vertical, which is a part of the Hetero Group, has a long history and has demonstrated expertise in the research, production, and marketing of chemical intermediates, APIs, ARVs, and finished dosage formulations. Hetero has long been a pioneer in the development and production of biopharmaceuticals employing cutting-edge technologies, and it has continued to do so. Hetero has 36 cutting-edge manufacturing sites that are thoughtfully positioned throughout the world. Additionally, the majority of our facilities have passed rigorous regulatory authority audits and approvals, including those from the US FDA, EU, TGA in Australia, MCC in South Africa, and others. We have over 300 medications in our portfolio, covering a wide range of therapeutic areas like HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology, and Immunology.